JP2018501201A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018501201A5 JP2018501201A5 JP2017526674A JP2017526674A JP2018501201A5 JP 2018501201 A5 JP2018501201 A5 JP 2018501201A5 JP 2017526674 A JP2017526674 A JP 2017526674A JP 2017526674 A JP2017526674 A JP 2017526674A JP 2018501201 A5 JP2018501201 A5 JP 2018501201A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- amino acid
- acid sequence
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462080784P | 2014-11-17 | 2014-11-17 | |
| US62/080,784 | 2014-11-17 | ||
| US14/943,752 | 2015-11-17 | ||
| PCT/US2015/061118 WO2016081475A1 (en) | 2014-11-17 | 2015-11-17 | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
| US14/943,752 US10500249B2 (en) | 2014-11-17 | 2015-11-17 | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018501201A JP2018501201A (ja) | 2018-01-18 |
| JP2018501201A5 true JP2018501201A5 (https=) | 2018-12-27 |
Family
ID=55960752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017526674A Pending JP2018501201A (ja) | 2014-11-17 | 2015-11-17 | 異常な線維芽細胞増殖および細胞外マトリックス沈着を特徴とする疾患、状態、またはプロセスを予防または処置するための組成物および方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10500249B2 (https=) |
| EP (1) | EP3220943A4 (https=) |
| JP (1) | JP2018501201A (https=) |
| KR (1) | KR20170083063A (https=) |
| CN (1) | CN107106650A (https=) |
| AU (1) | AU2015350151A1 (https=) |
| BR (1) | BR112017010238A2 (https=) |
| CA (1) | CA2967621A1 (https=) |
| MX (1) | MX2017006372A (https=) |
| RU (1) | RU2017121090A (https=) |
| SG (1) | SG11201703939XA (https=) |
| WO (1) | WO2016081475A1 (https=) |
| ZA (1) | ZA201703305B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020002206A (es) * | 2017-09-08 | 2020-07-20 | Bristol Myers Squibb Co | Factor de crecimiento de fibroblastos 21 (fgf-21) modificado para usarse en metodos para tratar la esteatohepatitis no alcoholica (nash). |
| US11725056B2 (en) | 2017-10-03 | 2023-08-15 | Cedars-Sinai Medical Center | Methods for targeting the immune checkpoint PD1 pathway for treating pulmonary fibrosis |
| CN108795935B (zh) * | 2018-05-23 | 2022-06-21 | 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) | 日本血吸虫SjELAV-like 1基因的siRNA及其应用 |
| CN110575540B (zh) * | 2018-06-07 | 2021-11-02 | 中山大学附属第六医院 | Pdgf抑制剂用于制备治疗肠道炎症疾病的药物方面的用途 |
| CN113134116B (zh) * | 2020-01-20 | 2022-09-06 | 山东威高宏瑞医学科技有限公司 | 内镜微创手术用的填充组合物及填充制剂 |
| CN113952821A (zh) * | 2021-07-22 | 2022-01-21 | 上海安居乐环保科技股份有限公司 | 一种罐区装卸区废气综合治理方法及系统 |
| CN113730551B (zh) * | 2021-09-02 | 2022-11-25 | 徐州医科大学 | Mmi-0100短肽化合物在制备胆汁淤积性肝病治疗药物中的应用 |
| CN118388635B (zh) * | 2024-06-24 | 2024-10-11 | 山东美瑞生物技术有限公司 | 一种提高皮肤修复功能的重组人源化胶原蛋白的制备方法 |
| CN118571492B (zh) * | 2024-08-02 | 2024-10-18 | 天津市胸科医院 | 基于组织边界影响的主动脉夹层患者并发症风险预测模型 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1521000A (en) | 1975-06-13 | 1978-08-09 | Syntex Puerto Rico Inc | Inhalation device |
| US4227522A (en) | 1978-09-05 | 1980-10-14 | Syntex Puerto Rico, Inc. | Inhalation device |
| US4192309A (en) | 1978-09-05 | 1980-03-11 | Syntex Puerto Rico, Inc. | Inhalation device with capsule opener |
| DK172541B1 (da) | 1982-10-08 | 1998-12-07 | Glaxo Group Ltd | Apparat til administrering af medikamenter til patienter og en medikamentpakning til brug i apparatet |
| US4778054A (en) | 1982-10-08 | 1988-10-18 | Glaxo Group Limited | Pack for administering medicaments to patients |
| DE3682457D1 (de) | 1985-07-30 | 1991-12-19 | Glaxo Group Ltd | Geraet zur verabreichung von medikamenten an patienten. |
| JPH05963A (ja) | 1990-04-13 | 1993-01-08 | Toray Ind Inc | ポリペプチド類組成物 |
| US6331318B1 (en) | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
| US5352461A (en) | 1992-03-11 | 1994-10-04 | Pharmaceutical Discovery Corporation | Self assembling diketopiperazine drug delivery system |
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| EP0733059B1 (en) | 1993-12-09 | 2000-09-13 | Thomas Jefferson University | Compounds and methods for site-directed mutations in eukaryotic cells |
| US6428771B1 (en) | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
| ES2261195T3 (es) | 1999-04-05 | 2006-11-16 | Mannkind Corporation | Metodo de formacion de particulas finas. |
| ES2569916T3 (es) | 1999-06-29 | 2016-05-13 | Mannkind Corporation | Formulaciones farmacéuticas que comprenden insulina complejada con una dicetopiperazina |
| ATE486064T1 (de) | 2004-08-20 | 2010-11-15 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
| KR20130066695A (ko) | 2004-08-23 | 2013-06-20 | 맨카인드 코포레이션 | 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염 |
| CN101014321A (zh) | 2004-08-23 | 2007-08-08 | 曼金德公司 | 5型磷酸二酯酶抑制剂的肺部给予 |
| MX373000B (es) | 2005-09-14 | 2020-05-21 | Mannkind Corp | Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas. |
| EP1986679B1 (en) | 2006-02-22 | 2017-10-25 | MannKind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| DK2617431T3 (en) * | 2007-01-10 | 2017-07-10 | Purdue Research Foundation | Polypeptide inhibitors of HSP27 kinase and applications therefor |
| NL1033850C2 (nl) | 2007-05-15 | 2008-11-18 | 3Force B V | Brandersysteem met voorgemengde branders en vlam-overdrachtsmiddelen. |
| WO2009021137A2 (en) | 2007-08-07 | 2009-02-12 | Purdue Research Foundation | Kinase inhibitors and uses thereof |
| CN102256613B (zh) * | 2008-10-20 | 2014-09-10 | 莫伊莱麦屈克斯公司 | 用于治疗或者预防粘连的多肽 |
| EP2378875B1 (en) * | 2008-12-10 | 2018-05-30 | Purdue Research Foundation | Cell-permeant peptide-based inhibitor of kinases |
| US20130115256A1 (en) * | 2010-05-24 | 2013-05-09 | Cynthia Lander | Methods for treating or preventing vascular graft failure |
| KR101862291B1 (ko) | 2011-04-12 | 2018-05-29 | 모레 매트릭스 인코포레이티드 | 이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정을 예방하거나 치료하기 위한 조성물 및 방법 |
| WO2013134636A1 (en) | 2012-03-09 | 2013-09-12 | Purdue Research Foundation | Compositions and methods for delivery of kinase inhibiting peptides |
| EP2931272A1 (en) * | 2012-12-12 | 2015-10-21 | The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System | Methods of treating hepatic fibrosis and associated diseases by regulating rev-erb activity |
-
2015
- 2015-11-17 JP JP2017526674A patent/JP2018501201A/ja active Pending
- 2015-11-17 CA CA2967621A patent/CA2967621A1/en not_active Abandoned
- 2015-11-17 AU AU2015350151A patent/AU2015350151A1/en not_active Abandoned
- 2015-11-17 SG SG11201703939XA patent/SG11201703939XA/en unknown
- 2015-11-17 MX MX2017006372A patent/MX2017006372A/es unknown
- 2015-11-17 US US14/943,752 patent/US10500249B2/en not_active Expired - Fee Related
- 2015-11-17 CN CN201580062363.0A patent/CN107106650A/zh active Pending
- 2015-11-17 EP EP15861651.6A patent/EP3220943A4/en not_active Withdrawn
- 2015-11-17 BR BR112017010238-2A patent/BR112017010238A2/pt not_active Application Discontinuation
- 2015-11-17 RU RU2017121090A patent/RU2017121090A/ru not_active Application Discontinuation
- 2015-11-17 WO PCT/US2015/061118 patent/WO2016081475A1/en not_active Ceased
- 2015-11-17 KR KR1020177014506A patent/KR20170083063A/ko not_active Withdrawn
-
2017
- 2017-05-12 ZA ZA2017/03305A patent/ZA201703305B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018501201A5 (https=) | ||
| RU2017121090A (ru) | Композиции и способы для профилактики или лечения заболеваний, состояний или процессов, характеризующихся аберрантной пролиферацией фибробластов и накоплением внеклеточного матрикса | |
| JP2014533235A5 (https=) | ||
| Van Dijk et al. | Targeted therapies in liver fibrosis: combining the best parts of platelet-derived growth factor BB and interferon gamma | |
| JP6355032B2 (ja) | 新規組換え二機能性融合タンパク質、それらの調製および使用 | |
| JP2023025005A (ja) | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 | |
| JP2020121984A (ja) | 抗ｖｅｇｆ抗体での治療 | |
| EP2170366B1 (en) | Use of tlr-2 antagonists for treatment of reperfusion injury and tissue damage | |
| O'Brien et al. | Evaluation of merocyanine 540-sensitized photoirradiation as a means to inactivate enveloped viruses in blood products | |
| CN108136025A (zh) | 一种使用免疫调节治疗癌症的新颖方法 | |
| US20090263389A1 (en) | Use of TGF-Beta Antagonists to Treat or to Prevent Chronic Transplant Rejection | |
| RU2013150249A (ru) | Композиции и способы профилактики или лечения заболеваний, состояний или процессов, характеризуемых аберрантной пролиферацией фибробластов и отложением внеклеточного матрикса | |
| AU2019366366B2 (en) | Therapeutic combinations of TDFRPs and additional agents and methods of use | |
| KR20170029576A (ko) | 골형성단백질의 치료적 용도 | |
| US20040266687A1 (en) | Compositions and methods comprising protein activated receptor antagonists | |
| KR20160093076A (ko) | 암의 치료용 조합 제조물 | |
| KR20220015375A (ko) | Ｓｅｐｈｂ4-ｈｓａ 융합 단백질을 이용한 암의 치료 | |
| Zhao et al. | Inhibition of tumor angiogenesis and tumor growth by the DSL domain of human Delta-like 1 targeted to vascular endothelial cells | |
| WO2012118042A1 (ja) | 悪性腫瘍転移抑制用医薬 | |
| JP2017509633A5 (https=) | ||
| EP3920961A2 (en) | Growth hormone-releasing hormone antagonists and uses thereof | |
| Ellmers et al. | (Pro) renin receptor blockade ameliorates cardiac injury and remodeling and improves function after myocardial infarction | |
| US11571455B2 (en) | Methods and compositions for treating alcoholic liver disease | |
| JP7182793B2 (ja) | 病理学的腎組織損傷を予防及び治療するための方法 | |
| JP6782932B2 (ja) | Ｎｐｒ−ａアゴニストの新規用途 |